| Cancer | ID | Symbol | Immune Pathway | P value | FDR value | ES value | Score | number |
|---|---|---|---|---|---|---|---|---|
| SARC | MIMAT0004565 | hsa-miR-218-1-3p | Cytokines | 2.283e-03 | 1.941e-02 | 0.4116 | 0.9954 | 82 |
| SARC | MIMAT0004567 | hsa-miR-219a-1-3p | Cytokines | 1.934e-03 | 3.288e-02 | 0.3594 | 0.9961 | 75 |
| SARC | MIMAT0004568 | hsa-miR-221-5p | Antigen Processing and Presentation | 1.905e-03 | 1.131e-02 | 0.6217 | 0.9962 | 53 |
| SARC | MIMAT0004568 | hsa-miR-221-5p | Natural Killer Cell Cytotoxicity | 1.957e-03 | 1.131e-02 | 0.4728 | 0.9961 | 42 |
| SARC | MIMAT0004568 | hsa-miR-221-5p | TCR signaling Pathway | 1.996e-03 | 1.131e-02 | 0.4715 | 0.996 | 26 |
| SARC | MIMAT0004569 | hsa-miR-222-5p | Antigen Processing and Presentation | 1.976e-03 | 1.680e-02 | 0.6504 | 0.996 | 50 |
| SARC | MIMAT0004569 | hsa-miR-222-5p | Natural Killer Cell Cytotoxicity | 1.961e-03 | 1.680e-02 | 0.4839 | 0.9961 | 29 |
| SARC | MIMAT0004570 | hsa-miR-223-5p | Antigen Processing and Presentation | 1.412e-03 | 3.683e-03 | 0.5912 | 0.9972 | 49 |
| SARC | MIMAT0004570 | hsa-miR-223-5p | Antimicrobials | 1.205e-03 | 3.683e-03 | 0.4932 | 0.9976 | 95 |
| SARC | MIMAT0004570 | hsa-miR-223-5p | BCR Signaling Pathway | 1.527e-03 | 3.683e-03 | 0.6296 | 0.9969 | 19 |
| SARC | MIMAT0004570 | hsa-miR-223-5p | Chemokines | 1.464e-03 | 3.683e-03 | 0.5554 | 0.9971 | 26 |
| SARC | MIMAT0004570 | hsa-miR-223-5p | Cytokines | 1.222e-03 | 3.683e-03 | 0.4595 | 0.9976 | 68 |
| SARC | MIMAT0004570 | hsa-miR-223-5p | Interleukins | 1.733e-03 | 3.683e-03 | 0.6762 | 0.9965 | 8 |